ArticleDiabetes & metabolism journal2022

Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study.

Hwi Seung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.